Seres Therapeutics, Inc.MCRBNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$6.98M
↑ 108% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-92.37M
Historical baseline
PeriodValueYoY Change
TTM$6.98M+105.8%
2024$-120.30M+33.7%
2023$-181.42M-6.1%
2022$-170.93M-201.4%
2021$-56.72M+26.6%
2020$-77.31M-24.3%
2019$-62.17M+31.7%
2018$-91.08M-10.9%
2017$-82.12M+7.3%
2016$-88.63M-